Oct 16, 2020 | Video Transcripts
Paula Bickley, vice president of market access for biologics at McKesson and one of the featured speakers at the 4th Annual PBMI Specialty Rx Forum, spoke with Managed Healthcare Executive® Senior Editor Peter Wehrwein. Peter Wehrwein, Managed Healthcare Executive®... Jul 20, 2020 | Video Transcripts
Expert pharmacists provide community physicians with recommendations for optimizing success on treatment for patients with chronic lymphocytic leukemia (CLL). Alison Duffy, PharmD, BCOP: What are your recommendations, Dr Steeves, for physicians in the community to... Jul 17, 2020 | Video Transcripts
Key opinion leaders discuss which characteristics of oral therapies need to be managed by pharmacists. Alison Duffy, PharmD, BCOP: We talked a little bit about the efficacy and safety information. What characteristics of the oral therapies that we haven’t... Jul 17, 2020 | Video Transcripts
A comparison of the safety and efficacy of orally and intravenously administered oncolytics. Alison Duffy, PharmD, BCOP: Dr Steeves, what has been your experience with efficacy and safety of the oral agents versus IV [intravenous] in terms of best practices for... Jul 16, 2020 | Video Transcripts
Key opinion leaders discuss trials focusing on patient populations with newly diagnosed chronic lymphocytic leukemia (CLL). Alison Duffy, PharmD, BCOP: I’d love to hear your thoughts on other treatment options besides ibrutinib in a newly diagnosed setting and... Jul 16, 2020 | Video Transcripts
Experts in the field of chronic lymphocytic management (CLL) consider how MRD (minimum residual disease) testing affects the use of limited duration therapy. Alison Duffy, PharmD, BCOP: What are your thoughts on the limited duration of therapy based on some of the... 